Production (Stage)
ArriVent BioPharma, Inc.
AVBP
$20.40
-$0.23-1.12%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -19.55% | -22.62% | -5.29% | -5.90% | 111.05% |
| Total Receivables | 1.00% | 0.00% | -33.33% | -14.29% | 14.98% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 200.98% | -64.33% | -6.86% | -15.75% | 295.11% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 10.67% | -8.77% | 0.44% | 1.41% | -8.19% |
| Total Current Assets | -18.15% | -22.37% | -5.22% | -5.79% | 104.72% |
|
|
|||||
| Total Current Assets | -18.15% | -22.37% | -5.22% | -5.79% | 104.72% |
| Net Property, Plant & Equipment | -22.08% | -17.65% | -14.61% | -12.40% | -14.09% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 39.68% | 0.00% | 0.80% | 15.74% | -96.20% |
| Total Assets | -21.62% | -6.07% | -5.23% | -5.79% | 101.01% |
|
|
|||||
| Total Accounts Payable | 15.39% | -18.60% | 21.88% | -6.98% | -9.58% |
| Total Accrued Expenses | -36.60% | 28.68% | 27.35% | 41.91% | -17.55% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -14.81% | 3.18% | 3.29% | 3.40% | 5.00% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -25.01% | 13.93% | 25.33% | 21.26% | -14.17% |
|
|
|||||
| Total Current Liabilities | -25.01% | 13.93% | 25.33% | 21.26% | -14.17% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -75.00% | -42.86% | -28.99% | -22.03% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -25.08% | 13.60% | 24.78% | 20.57% | -14.29% |
|
|
|||||
| Common Stock & APIC | 1.83% | 0.20% | 0.28% | 0.16% | 10,497.27% |
| Retained Earnings | -27.02% | -9.48% | -10.43% | -12.48% | -11.03% |
| Treasury Stock & Other | 91.94% | -- | -- | -- | -- |
| Total Common Equity | -21.39% | -7.15% | -6.46% | -6.63% | 307.40% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -21.39% | -7.15% | -6.46% | -6.63% | 307.40% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -21.39% | -7.15% | -6.46% | -6.63% | 110.00% |
|
|
|||||